Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Chest
|
October 9, 2022
Response
Alessia Comes, Christopher J Ryerson
Current Opinion in Pulmonary Medicine
|
July 15, 2022
Novel insights in fibrotic pulmonary sarcoidosis
Alessia Comes, Carmelo Sofia, Luca Richeldi
European Journal of Internal Medicine
|
August 27, 2020
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal?
Alessia Comes, Giacomo Sgalla, Luca Richeldi
Expert Opinion on Drug Safety
|
April 21, 2021
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis
Giacomo Sgalla, Alessia Comes, Luca Richeldi
Expert Opinion on Pharmacotherapy
|
June 4, 2024
Promising advances in treatments for the management of idiopathic pulmonary fibrosis
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Expert Opinion on Emerging Drugs
|
November 13, 2023
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Expert Opinion on Pharmacotherapy
|
December 15, 2021
Advances with pharmacotherapy for the treatment of interstitial lung disease
Alessia Comes, Giacomo Sgalla, Alessandro Perrotta, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2021
COVID-related fibrosis: insights into potential drug targets
Giacomo Sgalla, Alessia Comes, Marialessia Lerede, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 12, 2022
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Giacomo Sgalla, Tonia Magrì, Marialessia Lerede, et al.
Expert Review of Respiratory Medicine
|
April 2, 2023
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach
Alessia Comes, Giacomo Sgalla, Simone Ielo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Chest
|
October 9, 2022
Response
Alessia Comes, Christopher J Ryerson
Current Opinion in Pulmonary Medicine
|
July 15, 2022
Novel insights in fibrotic pulmonary sarcoidosis
Alessia Comes, Carmelo Sofia, Luca Richeldi
European Journal of Internal Medicine
|
August 27, 2020
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal?
Alessia Comes, Giacomo Sgalla, Luca Richeldi
Expert Opinion on Drug Safety
|
April 21, 2021
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis
Giacomo Sgalla, Alessia Comes, Luca Richeldi
Expert Opinion on Pharmacotherapy
|
June 4, 2024
Promising advances in treatments for the management of idiopathic pulmonary fibrosis
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Expert Opinion on Emerging Drugs
|
November 13, 2023
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Expert Opinion on Pharmacotherapy
|
December 15, 2021
Advances with pharmacotherapy for the treatment of interstitial lung disease
Alessia Comes, Giacomo Sgalla, Alessandro Perrotta, et al.
Expert Opinion on Investigational Drugs
|
November 29, 2021
COVID-related fibrosis: insights into potential drug targets
Giacomo Sgalla, Alessia Comes, Marialessia Lerede, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 12, 2022
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Giacomo Sgalla, Tonia Magrì, Marialessia Lerede, et al.
Expert Review of Respiratory Medicine
|
April 2, 2023
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach
Alessia Comes, Giacomo Sgalla, Simone Ielo, et al.
Page
of 2